Market revenue in 2023 | USD 23.2 million |
Market revenue in 2030 | USD 34.0 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.33% in 2023. Horizon Databook has segmented the Canada clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Government of Canada, the country is significant in the global clinical trials landscape. Canada held 4% of global clinical trials, making it a notable contributor. It ranks fourth in the number of clinical trial sites, indicating a strong infrastructure for conducting trials within the country.
In addition, Canada is recognized as the G7 leader in clinical trial efficiency, showcasing its high level of efficiency & effectiveness in conducting clinical trials relative to its population size. Furthermore, the multinational pharmaceutical companies conduct a substantial portion of their clinical trials in Canada, as the country has a world-class clinical trial environment.
The above factors are likely to contribute to Canada’s market growth over the forecast period. The Government of Canada has allocated funding to support various initiatives through the Strategic Innovation Fund (SIF) related to R&D, clinical trials, and manufacturing vaccines & therapeutic drugs to combat COVID-19.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Canada clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account